Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961518 · ClinicalTrials.gov registry record
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome
A clinical trial of MPS IVA and MPS VI, sponsored by Greenwood Genetic Center.
- Completed
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT01961518 is a study of MPS IVA and MPS VI that has completed, run by Greenwood Genetic Center. The registered enrollment target is 17 participants, below the 65-participant average among 5 other MPS IVA trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01961518, a study of MPS IVA and MPS VI, has completed, sponsored by Greenwood Genetic Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify patients with Morquio syndrome type A (MPS IVA) and Maroteaux-Lamy syndrome (MPS VI) who may have been missed or misdiagnosed due to atypical clinical features, a milder course, and/or negative urine screening. We will recruit participants who have certain hip and/or joint problems that could potentially be caused by one of these two genetic conditions through a chart review process conducted at Shriners Hospital for Children in Greenville, SC. Diagnostic testing will be performed for each participant to determine if he or she is affected by one of these two conditions. Results will be disclosed to all participants and their legal guardians, and appropriate follow up will be recommended for those who are found to have abnormal results.
Conditions Studied
Study Locations (1)
South Carolina
- Greenwood Genetic Center - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01961518
The ClinicalTrials.gov registry entry for NCT01961518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 65-participant average among 5 other MPS IVA trials with a reported enrollment target (74% lower). The listed sponsor is Greenwood Genetic Center, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with MPS IVA appearing as the primary indexed condition, and to 0 interventions.
NCT01961518 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01961518 about?
NCT01961518 is a clinical study titled "Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome". The purpose of this study is to identify patients with Morquio syndrome type A (MPS IVA) and Maroteaux-Lamy syndrome (MPS VI) who may have been missed or misdiagnosed due to atypical clinical features, a milder course, and/or negative urine screening. We will recruit participants who have certain hi...
What is the current status of trial NCT01961518?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2013-10. Estimated completion is 2015-05.
What conditions does trial NCT01961518 study?
This clinical trial studies the following conditions: MPS IVA, MPS VI, Maroteaux Lamy Syndrome, Morquio Syndrome A.
Who is sponsoring clinical trial NCT01961518?
This trial is sponsored by Greenwood Genetic Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01961518 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for MPS IVA
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Functional Assessment and Pathogenesis of Morquio A
RECRUITING
-
Cardiac Structure and Function in MPS
RECRUITING
-
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
RECRUITING · Phase 1
-
Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI
ACTIVE NOT RECRUITING · Phase 1
-
Gait Analysis in MPS IVA
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.